EGFR Thr790Leu as a Potential Resistance Mechanism to First-Generation EGFR Tyrosine Kinase Inhibitor May Respond to Osimertinib in Patients With Lung Adenocarcinoma

por Xiang, Chan, Zhang, Wei, Xiong, Li-Wen, Cai, Xu-Wei, Teng, Hao-Hua, Zhao, Rui-Ying, Shang, Zhan-Xian, Han-Zhang, Han, Zhang, Lu, Yan, Li, Chen, Zhi-Qiu, Han, Yu-Chen
Publicado 2021

A Classification Method Based on Principal Components of SELDI Spectra to Diagnose of Lung Adenocarcinoma

por Lin, Qiang, Peng, Qianqian, Yao, Feng, Pan, Xu-Feng, Xiong, Li-Wen, Wang, Yi, Geng, Jun-Feng, Feng, Jiu-Xian, Han, Bao-Hui, Bao, Guo-Liang, Yang, Yu, Wang, Xiaotian, Jin, Li, Guo, Wensheng, Wang, Jiu-Cun
Publicado 2012